Business Description
Cyfuse Biomedical KK
ISIN : JP3311800001
Compare
Compare
Traded in other countries / regions
4892.Japan IPO Date
2022-12-01Description
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.21 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | -1.22 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.83 | |||||
| Beneish M-Score | -0.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -25.9 | |||||
| 3-Year EBITDA Growth Rate | -19.5 | |||||
| 3-Year EPS without NRI Growth Rate | -17.8 | |||||
| 3-Year FCF Growth Rate | -21.8 | |||||
| 3-Year Book Growth Rate | 23.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.78 | |||||
| 9-Day RSI | 31.96 | |||||
| 14-Day RSI | 34.56 | |||||
| 6-1 Month Momentum % | -33.75 | |||||
| 12-1 Month Momentum % | -35.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.11 | |||||
| Quick Ratio | 6.02 | |||||
| Cash Ratio | 5.86 | |||||
| Days Inventory | 675.01 | |||||
| Days Sales Outstanding | 37.03 | |||||
| Days Payable | 40.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.4 | |||||
| Shareholder Yield % | 1.25 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.3 | |||||
| Operating Margin % | -1285.67 | |||||
| Net Margin % | -1103.48 | |||||
| FCF Margin % | -955.57 | |||||
| ROE % | -21.28 | |||||
| ROA % | -16.37 | |||||
| ROIC % | -97.77 | |||||
| ROC (Joel Greenblatt) % | -293.21 | |||||
| ROCE % | -18.85 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 57.28 | |||||
| PB Ratio | 1.23 | |||||
| Price-to-Tangible-Book | 1.23 | |||||
| EV-to-EBIT | -1.52 | |||||
| EV-to-EBITDA | -1.52 | |||||
| EV-to-Revenue | 16.5 | |||||
| EV-to-FCF | -1.7 | |||||
| Price-to-Net-Current-Asset-Value | 1.37 | |||||
| Price-to-Net-Cash | 1.45 | |||||
| Earnings Yield (Greenblatt) % | -65.59 | |||||
| FCF Yield % | -16.23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cyfuse Biomedical KK Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 60.882 | ||
| EPS (TTM) (円) | -84.843 | ||
| Beta | 0 | ||
| Volatility % | 18.68 | ||
| 14-Day RSI | 34.56 | ||
| 14-Day ATR (円) | 23.103198 | ||
| 20-Day SMA (円) | 482.2 | ||
| 12-1 Month Momentum % | -35.79 | ||
| 52-Week Range (円) | 430 - 883 | ||
| Shares Outstanding (Mil) | 8.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cyfuse Biomedical KK Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cyfuse Biomedical KK Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cyfuse Biomedical KK Frequently Asked Questions
What is Cyfuse Biomedical KK(TSE:4892)'s stock price today?
The current price of TSE:4892 is 円441.00. The 52 week high of TSE:4892 is 円883.00 and 52 week low is 円430.00.
When is next earnings date of Cyfuse Biomedical KK(TSE:4892)?
The next earnings date of Cyfuse Biomedical KK(TSE:4892) is .
Does Cyfuse Biomedical KK(TSE:4892) pay dividends? If so, how much?
Cyfuse Biomedical KK(TSE:4892) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers